Close Menu

NEW YORK – Aspira Women's Health, formerly known as Vermillion, reported after the close of the market on Thursday that its second quarter revenues were down 32 percent year over year.

For the quarter ended June 30, the company reported total revenues of $746,000, down from $1.1 million a year ago. Product revenues were down 32 percent to $743,000 from $1.1 million in Q2 2019. The company posted $3,000 in service revenue, down 93 percent from $42,000 in the year-ago quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.